MNM Bioscience, a technological start-up using genomic data and artificial intelligence algorithms to develop solutions for personalized medicine, received an $800 000 grant from the Eureka’s Eurostars Programme. The program is a funding instrument dedicated for innovative SMEs, and will support the development of MNM’s unique patient stratification tool for ovarian cancer patients.